Infant mouse model for the study of shedding and transmission during streptococcus pneumoniae monoinfection

Infection and Immunity

Volumn 84, Issue 9, 2016, Pages 2714-2722

  Ammar Zafar, M ^a   Kono, Masamitsu ^a,b   Wang, Yang ^a,c   Zangari, Tonia ^a   Weisera, Jeffrey N ^a  

^a NEW YORK UNIVERSITY   (United States)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^c TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL SHEDDING; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CONTROLLED STUDY; GENE LOCUS; GROUPS BY AGE; INFANT; INFLUENZA A; INFLUENZA A VIRUS; MIXED INFECTION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; ANIMAL; C57BL MOUSE; DISEASE MODEL; HETEROZYGOTE; ISOLATION AND PURIFICATION; MICROBIOLOGY; NEWBORN; PHYSIOLOGY; PNEUMOCOCCAL INFECTION; TRANSMISSION;

ANIMALS; ANIMALS, NEWBORN; BACTERIAL SHEDDING; CARRIER STATE; DISEASE MODELS, ANIMAL; MICE; MICE, INBRED C57BL; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 84984824015     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00416-16     Document Type: Article

References (30)

1. Bogaert D, De Groot R, Hermans PWM. 2004. Streptococcus colonisation:the key to pneumococcal disease. Lancet Infect Dis 4:144-154. http://dx.doi.org/10.1016/S1473-3099(04)00938-7.
2. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T. 2009. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years:global estimates. Lancet 374:893-902. http://dx.doi.org/10.1016/S0140-6736(09)61204-6.
3. Musher DM. 2003. How contagious are common respiratory tract infections? N Engl J Med 348:1256-1266. http://dx.doi.org/10.1056/NEJMra021771.
4. Siegel SJ, Weiser JN. 2015. Mechanisms of bacterial colonization of the respiratory tract. Annu Rev Microbiol 69:425-444. http://dx.doi.org/10.1146/annurev-micro-091014-104209.
5. Hodges RG, MacLeod CM, Bernhard WG. 1946. Epidemic pneumococcal pneumonia; pneumococcal carrier studies. Am J Hyg 44:207-230.
6. Rodrigues F, Foster D, Nicoli E, Trotter C, Vipond B, Muir P, Gonçalves G, Januário L, Finn A. 2013. Relationships between rhinitis symptoms, respiratory viral infections and nasopharyngeal colonization with Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus in children attending daycare. Pediatr Infect Dis J 32:227-232. http://dx.doi.org/10.1097/INF.0b013e31827687fc.
7. Richard AL, Siegel SJ, Erikson J, Weiser JN. 2014. TLR2 signaling decreases transmission of Streptococcus pneumoniae by limiting bacterial shedding in an infant mouse influenza A co-infection model. PLoS Pathog 10:e1004339. http://dx.doi.org/10.1371/journal.ppat.1004339.
8. Gwaltney JM, Jr, Sande MA, Austrian R, Hendley JO. 1975. Spread of Streptococcus pneumoniae in families. II. Relation of transfer of S. pneumoniae to incidence of colds and serum antibody. J Infect Dis 132:62-68.
9. Vu HTT, Yoshida LM, Suzuki M, Nguyen HAT, Nguyen CDL, Nguyen ATT, Oishi K, Yamamoto T, Watanabe K, Vu TD. 2011. Association between nasopharyngeal load of Streptococcus pneumoniae, viral coinfection, and radiologically confirmed pneumonia in Vietnamese children. Pediatr Infect Dis J 30:11-18. http://dx.doi.org/10.1097/INF.0b013e3181f111a2.
10. Siegel SJ, Roche AM, Weiser JN. 2014. Influenza promotes pneumococcal growth during coinfection by providing host sialylated substrates as a nutrient source. Cell Host Microbe 16:55-67. http://dx.doi.org/10.1016/j .chom.2014.06.005.
11. McCullers JA. 2014. The co-pathogenesis of influenza viruses with bacteria in the lung. Nat Rev Microbiol 12:252-262. http://dx.doi.org/10.1038/nrmicro3231.
12. Short KR, Reading PC, Wang N, Diavatopoulos DA, Wijburg OL. 2012. Increased nasopharyngeal bacterial titers and local inflammation facilitate transmission of Streptococcus pneumoniae. mBio 3(5):e00255-12. http://dx.doi.org/10.1128/mBio.00255-12.
13. Diavatopoulos DA, Short KR, Price JT, Wilksch JJ, Brown LE, Briles DE, Strugnell RA, Wijburg OL. 2010. Influenza A virus facilitates Streptococcus pneumoniae transmission and disease. FASEB J 24:1789-1798. http://dx.doi.org/10.1096/fj.09-146779.
14. Numminen E, Chewapreecha C, Turner C, Goldblatt D, Nosten F, Bentley SD, Turner P, Corander J. 2015. Climate induces seasonality in pneumococcal transmission. Sci Rep 5:11344. http://dx.doi.org/10.1038/srep11344.
15. Kadioglu A, Weiser JN, Paton JC, Andrew PW. 2008. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol 6:288-301. http://dx.doi.org/10.1038/nrmicro1871.
16. DeBardeleben HK, Lysenko ES, Dalia AB, Weiser JN. 2014. Tolerance of a phage element by Streptococcus pneumoniae leads to a fitness defect during colonization. J Bacteriol 196:2670-2680. http://dx.doi.org/10.1128/JB.01556-14.
17. Tettelin H, Nelson KE, Paulsen IT, Eisen JA, Read TD, Peterson S, Heidelberg J, DeBoy RT, Haft DH, Dodson RJ, Durkin AS, Gwinn M, Kolonay JF, Nelson WC, Peterson JD, Umayam LA, White O, Salzberg SL, Lewis MR, Radune D, Holtzapple E, Khouri H, Wolf AM, Utterback TR, Hansen CL, McDonald LA, Feldblyum TV, Angiuoli S, Dickinson T, Hickey EK, Holt IE, Loftus BJ, Yang F, Smith HO, Venter JC, Dougherty BA, Morrison DA, Hollingshead SK, Fraser CM. 2001. Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science 293:498-506. http://dx.doi.org/10.1126/science.1061217.
18. Roche AM, King SJ, Weiser JN. 2007. Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice. Infect Immun 75:2469-2475. http://dx.doi.org/10.1128/IAI.01972-06.
19. McCarty M, Avery OT. 1946. Studies on the chemical nature of the substance inducing transformation of pneumococcal types: III. An improved method for the isolation of the transforming substance and its application to pneumococcus types II, III and VI. J Exp Med 83:97-104.
20. Li Y, Thompson CM, Lipsitch M. 2014. A modified Janus cassette (sweet Janus) to improve allelic replacement efficiency by high-stringency negative selection in Streptococcus pneumoniae. PLoS One 9:e100510. http://dx .doi.org/10.1371/journal.pone.0100510.
21. Liang S, Mozdzanowska K, Palladino G, Gerhard W. 1994. Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. J Immunol 152:1653-1661.
22. Siegel SJ, Tamashiro E, Weiser JN. 2015. Clearance of pneumococcal colonization in infants is delayed through altered macrophage trafficking. PLoS Pathog 11:e1005004. http://dx.doi.org/10.1371/journal.ppat.1005004.
23. Nelson AL, Roche AM, Gould JM, Chim K, Ratner AJ, Weiser JN. 2007. Capsule enhances pneumococcal colonization by limiting mucusmediated clearance. Infect Immun 75:83-90. http://dx.doi.org/10.1128/IAI.01475-06.
24. Basset A, Trzcinski K, Hermos C, O'Brien KL, Reid R, Santosham M, McAdam AJ, Lipsitch M, Malley R. 2007. Association of the pneumococcal pilus with certain capsular serotypes but not with increased virulence. J Clin Microbiol 45:1684-1689. http://dx.doi.org/10.1128/JCM.00265-07.
25. Turner P, Melchiorre S, Moschioni M, Barocchi MA, Turner C, Watthanaworawit W, Kaewcharernnet N, Nosten F, Goldblatt D. 2012. Assessment of Streptococcus pneumoniae pilus islet-1 prevalence in carried and transmitted isolates from mother-infant pairs on the Thailand-Burma border. Clin Microbiol Infect 18:970-975. http://dx.doi.org/10.1111/j.1469-0691.2011.03711.x.
26. Hammerschmidt S. 2006. Adherence molecules of pathogenic pneumococci. Curr Opin Microbiol 9:12-20. http://dx.doi.org/10.1016/j.mib.2005.11.001.
27. Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM. 2005. Superspreading and the effect of individual variation on disease emergence. Nature 438:355-359. http://dx.doi.org/10.1038/nature04153.
28. Davis S, Deloria-Knoll M, Kassa HT, O'Brien KL. 2013. Impact of pneumococcal conjugate vaccines on nasopharyngeal invasive disease among unvaccinated people: review of evidence on indirect effects. Vaccine 32:133-145. http://dx.doi.org/10.1016/j.vaccine.2013.05.005.
29. Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, Thomas AR, Harrison LH, Bennett NM, Farley MM, Facklam RR, Jorgensen JH, Besser J, Zell ER, Schuchat A, Whitney CG. 2006. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.NEngl J Med 354:1455-1463. http://dx.doi.org/10.1056/NEJMoa051642.
30. Moore MR, Link-Gelles R, Schaffner W, Lynfield R, Lexau C, Bennett NM, Petit S, Zansky SM, Harrison LH, Reingold A, Miller L, Scherzinger K, Thomas A, Farley MM, Zell ER, Taylor TH, Pondo T, Rodgers L, McGee L, Beall B, Jorgensen JH, Whitney CG. 2015. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. Lancet Infect Dis 15:301-309. http://dx .doi.org/10.1016/S1473-3099(14)71081-3.